Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration

– Submission seeks approval of momelotinib for the treatment of myelofibrosis – SAN MATEO, Calif.–(BUSINESS WIRE)–Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for momelotinib, … [Read more…]

Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for the Second Quarter 2022 Earnings Release and Conference Call

MILWAUKEE–(BUSINESS WIRE)–Physicians Realty Trust (NYSE:DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized, and the Company has declared, a quarterly cash dividend of $0.23 per common share and unit for the quarter ending June 30, 2022. “We are proud to declare and pay our 36th consecutive quarterly dividend. Cash flows from … [Read more…]

Worldwide High-flow Nasal Cannula Industry to 2027 – Rising Incidence of Respiratory Disorders is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “High-flow Nasal Cannula Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The High-flow Nasal Cannula market is projected to grow with a CAGR of nearly 12.4% over the forecast period. Companies Mentioned ResMed Fisher & Paykel Healthcare Limited Devatec Teleflex Incorporated Smiths Medical … [Read more…]

Global Syndromic Multiplex Diagnostic Market Report (2022 to 2027) – Increasing Demand for Accurate and Rapid Results is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Syndromic Multiplex Diagnostic Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The syndromic multiplex diagnostic market is anticipated to grow with a CAGR of nearly 7.2% during the forecast period. Companies Mentioned BIOMERIEUX SA Qiagen Luminex Corporation Applied BioCode Akonni Biosystems Mesa Biotech … [Read more…]

Global Bacterial Conjunctivitis Market to 2032 – Insights, Epidemiology and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Bacterial Conjunctivitis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Bacterial Conjunctivitis, historical and forecasted epidemiology as well as the Bacterial Conjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. … [Read more…]

Insights on the Medical Imaging Global Market to 2027 – Featuring GE Healthcare, Koninklijke Philips and PerkinElmer Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Medical Imaging Market Research Report by Modality (Computed Tomography, Fluoroscopy, and Mammography), End-user, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Medical Imaging Market size was estimated at USD 16.84 billion in … [Read more…]

HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology

HONG KONG & INGELHEIM, Germany–(BUSINESS WIRE)–Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited (BIVF) in a strategic co-incubation collaboration to promote and nurture startups on research and development for infectious diseases and immunology. HKSTP is dedicated to collaborating with sector leaders in building the … [Read more…]

IFPMA: Pharmaceutical Industry Expresses Deep Disappointment With Decision on Waiving Intellectual Property Rights Adopted at the World Trade Organization Ministerial Conference

IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken to adopt a TRIPS waiver, despite intellectual property (IP) not being a barrier to vaccine scale-up and wide acknowledgment of vaccines surplus. IP has enabled the rapid research and development of several effective vaccines against COVID-19 and underpinned the more … [Read more…]

Global Microneedle Measurable Chronic Disease Biomarkers Market Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Microneedle Measurable Chronic Disease Biomarkers” report has been added to ResearchAndMarkets.com’s offering. Biomarkers are a key medical product development tool capable of facilitating development of medical products and spurring innovation. When used in the right context, biomarkers have the potential to help expedite patient access to safe and effective treatments by reducing the … [Read more…]

Seoul Semiconductor: The #1 in Patent Power Pre-empting the Future with 2nd Generation LED Technologies

Seoul Semiconductor Ranked Top ANSAN, South Korea–(BUSINESS WIRE)–#KOSDAQ046890—Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a global optical semiconductor company, announced that Seoul Semiconductor and Seoul Viosys (hereafter referred to as Seoul) are Korea’s #1 optical semiconductor (LED) companies and are among the world’s #1 patent-powered companies. Seoul is ranked first in the world in the ultraviolet … [Read more…]